(Reuters) - AstraZeneca Plc’s head of oncology research, Jose Baselga, has died at the age of 61, the company said on Sunday.
"An outstanding scientific leader, José leaves a lasting legacy in the scientific community and here at AstraZeneca," the company's Chief Executive Officer Pascal Soriot said bit.ly/3lye6YU in a statement.
The statement did not give a cause of death but Spanish newspaper La Vanguardia said Baselga had died of Creutzfeldt-Jakob disease, a rare brain condition.
Baselga joined AstraZeneca in 2019. He previously worked as Memorial Sloan Kettering Cancer Center’s chief medical officer. He had also been chief of hematology/oncology at the Massachusetts General Hospital Cancer Center and a professor at Harvard Medical School.
Reporting by Radhika Anilkumar in Bengaluru; Editing by Frances Kerry
Our Standards: The Thomson Reuters Trust Principles.